LyndaASzczechMD

Vice President of Clinical Development, Fibrogen, San Francisco CA

Dr. Szczech is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

127 citations
Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women
Lytt I. Gardner, Scott D. Holmberg, John Williamson, Lynda A. Szczech, Charles C. J. Carpenter
Journal of Acquired Immune Deficiency Syndromes. 2003-02-01
157 citations
White blood cells as a novel mortality predictor in haemodialysis patients
Donal N. Reddan, Preston S. Klassen, Lynda A. Szczech, Joseph A. Coladonato, Susan O'Shea
Nephrology, Dialysis, Transplantation. 2003-06-01
1958 citations
Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
Ajay K. Singh, Lynda A. Szczech, Kezhen L. Tang, Huiman X. Barnhart, Shelly Sapp
The New England Journal of Medicine. 2006-11-16

Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 StudyFebruary 11th, 2021

Analysis Of Associations Between Anemia Correction In CKD And MORTALITY: ChoirNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2010
An Observational Study Of The Pharmacokinetics Of Efavirenz, Nevirapine, And LOPNational Center For Research Resources2005
Epidemiology And Clinical Course Of HIV NephropathyNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2004